CYTARABINE, CYTARABINE, Liposomal Annamycin, 0.9% Sodium Chloride Injection, USP/Ph. Eur./BP/JP
MB-108
Phase 3 small_molecule active
Quick answer
CYTARABINE, CYTARABINE, Liposomal Annamycin, 0.9% Sodium Chloride Injection, USP/Ph. Eur./BP/JP for Acute Myeloid Leukemia is a Phase 3 program (small_molecule) at Moleculin Biotech with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Moleculin Biotech
- Indication
- Acute Myeloid Leukemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active